Health Ministry revises Drugs Rules 1945; permits tablet and capsule quantities exceeding 10 to be packaged in multiples of both 7 and 5 by Anum Ahmed | Mar 21, 2024 | Central, OPS, PharmaceuticalsIn furtherance to what we reported earlier (please refer to e-mails in trail), the Ministry of... Read More
CDSCO mandates online submission of Period Safety Update Reports (PSURs) through Sugam Portal, offline submissions to be discontinued from 11th March, 2024 by Anum Ahmed | Feb 29, 2024 | Central, OPS, PharmaceuticalsWith a view to streamline the regulatory submission procedure, the Central Drugs Standards Control... Read More
Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul by Lexplosion | Feb 28, 2024 | Compliance, Legal analysis, PharmaceuticalsIf you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More
Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI by Anum Ahmed | Feb 12, 2024 | Central, OPS, PharmaceuticalsMinistry of Health and Family Welfare has issued a Notification dated February 5, 2024, revoking... Read More
Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023 by Lexplosion | Feb 1, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Ayush has invited objections and suggestions on proposed amendments to Schedule I... Read More
CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs by Lexplosion | Aug 1, 2023 | Central, OPS, PharmaceuticalsCentral Drugs Standard Control Organization has issued a FAQ for implementation of the requirement... Read More